AviGenics
Athens
About AviGenics
AviGenics is a biotechnology company developing therapeutic proteins for oncology, infectious diseases and autoimmune diseases. AviGenics’ proprietary technology produces therapeutic proteins with human-like glycosylation, leading to well tolerated products with increased half-life and enhanced clinical efficacy. Using this technology, the Company has demonstrated that it can achieve commercially feasible levels of production and purification for therapeutic proteins.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $10.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2000)
- Website: avigenics.com
- Phone: +1 (706)227-1170
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/avigenics-3029309 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.